advancing the treatment of attrv-pn: what's in the pipeline?
Published 3 months ago • 12 plays • Length 5:30Download video MP4
Download video MP3
Similar videos
-
2:43
3d video understanding attr amyloidosis
-
16:12
transthyretin amyloid and new treatment options
-
7:41
“behind the mystery: rare & genetic series – ttr amyloidosis
-
5:00
attr amyloidosis: familial vs wild-type
-
15:28
wild-type transthyretin cardiac amyloidosis - mayo clinic
-
2:01
attr-cm transthyretin amyloidosis: genetic analysis | protocol preview
-
11:47
#attr #amyloidosis #tafamidis #cardiomyopathy #neuropathy #drnarendrakumar #vutrisiran
-
8:45
attr amyloidosis - behind the mystery
-
3:20
david, living with hereditary attr (hattr) amyloidosis
-
39:58
attr cardiac amyloidosis
-
1:14:18
joint iacrlrd/iach webinar: targeted diagnosis and therapy of npm1-mutated aml
-
14:23
diagnosing attr-cm and treatment options
-
1:25
inaugural treatment for transthyretin amyloid cardiomyopathy
-
16:33
transthyretin amyloid and new treatment options
-
9:25
pfizer's vyndaqel and vyndamax (tafamidis) treatments for ttr amyloidosis
-
3:46
living with transthyretin amyloidosis (attr)
-
20:11
hereditary attr (hattr) amyloidosis: a rare, inherited, rapidly progressive condition
-
17:46
ttr cardiac amyloid-how common and how to diagnose
-
1:03:47
ccc 2019: abcd of attr amyloidosis - a practical approach
-
13:01
newly fda approved amvuttra™ for treatment of hattr amyloidosis with polyneuropathy
-
1:02
how the amyloidosis treatment landscape has transformed in recent years
-
1:08
challenges in understanding and diagnosing attr amyloidosis